Hohimer Wealth Management LLC Cuts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Hohimer Wealth Management LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 82.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,586 shares of the healthcare conglomerate's stock after selling 7,707 shares during the quarter. Hohimer Wealth Management LLC's holdings in UnitedHealth Group were worth $831,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Brighton Jones LLC grew its position in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after buying an additional 28,231 shares during the period. Revolve Wealth Partners LLC grew its holdings in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after acquiring an additional 2,324 shares during the period. Bank Pictet & Cie Europe AG boosted its position in shares of UnitedHealth Group by 3.9% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock worth $133,373,000 after purchasing an additional 9,872 shares during the last quarter. Proficio Capital Partners LLC increased its holdings in UnitedHealth Group by 52.1% in the fourth quarter. Proficio Capital Partners LLC now owns 3,734 shares of the healthcare conglomerate's stock valued at $1,889,000 after purchasing an additional 1,279 shares during the last quarter. Finally, Wellington Shields & Co. LLC boosted its holdings in UnitedHealth Group by 17.6% during the fourth quarter. Wellington Shields & Co. LLC now owns 241 shares of the healthcare conglomerate's stock worth $122,000 after buying an additional 36 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on UNH shares. Argus lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Royal Bank Of Canada reduced their target price on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. TD Securities reaffirmed a "hold" rating and set a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, Wolfe Research dropped their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a report on Tuesday, May 20th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus price target of $415.00.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director owned 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Stephen J. Hemsley purchased 86,700 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The shares were purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer directly owned 679,493 shares in the company, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock worth $31,607,768 over the last quarter. Insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded down $3.73 during midday trading on Monday, reaching $300.37. The company had a trading volume of 10,659,781 shares, compared to its average volume of 11,129,027. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The company's 50 day moving average price is $314.52 and its 200 day moving average price is $439.94. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a market cap of $272.48 billion, a P/E ratio of 12.58, a P/E/G ratio of 1.46 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the previous year, the company posted $6.91 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.94%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. UnitedHealth Group's payout ratio is presently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.